The Trump administration highlighted a potential autism risk from prenatal acetaminophen use, but studies demonstrate conflicting evidence. The Trump administration warned today of a potential link ...

Tirzepatide had an incremental cost-effectiveness ratio of $57,400 per lifetime quality-adjusted life-year (QALY), ...

Despite moderate out-of-pocket spending, Medicare beneficiaries with near low income face the highest rates of health care affordability problems, according to a study published today in JAMA Network ...

Ana Baramidze, MD, head of the Department of Clinical Researches at the Todua Clinic in Tbilisi, Georgia, explained how the efficacy results of cemiplimab can provide flexibility in treatment options ...

In this interview, Patel recommends that providers adapt by updating financial assistance policies, expanding patient financing options, and emphasizing price transparency to better inform patients of ...

Same-sex couples now report higher insurance coverage than different-sex couples, but disparities by income, geography, and marital status remain.

It's important to enhance MG treatment outcomes with strong provider-patient relationships and ongoing monitoring, explain Ratna Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD.

Refat Rasul Srejon, MPH, recommends employer coverage for substance use care and follow-up, plus research on local treatment and drug trends.

New research highlights caregiver perspectives to improve colorectal cancer screening access for individuals with intellectual and developmental disabilities.

ET, a chronic myeloproliferative neoplasm (MPN), is characterized by overproduction of platelets, often linked to mutations ...

Andrea Iannucci, PharmD, BCOP, assistant chief pharmacist at UC Davis Health, spoke with The American Journal of Managed Care ® (AJMC ®) about the accessibility of new formulary drugs in oncology and ...

Low-dose aspirin significantly reduced colorectal cancer (CRC) recurrence among patients with PIK3CA hotspot mutations and ...